We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+11.45%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$76M
AUM Growth
-$11.1M
Cap. Flow
+$112M
Cap. Flow %
147.28%
Top 10 Hldgs %
38.02%
Holding
408
New
159
Increased
53
Reduced
54
Closed
131

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$3.17M
2
K
Kellanova
K
+$2.19M
3
FL
Foot Locker
FL
+$2.04M
4
GIS icon
General Mills
GIS
+$1.95M
5
LULU icon
lululemon athletica
LULU
+$1.74M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.7M
2
JPM icon
JPMorgan Chase
JPM
+$3.58M
3
GILD icon
Gilead Sciences
GILD
+$3.38M
4
STZ icon
Constellation Brands
STZ
+$2.74M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2M

Sector Composition

Rank Sector Weight
1 Healthcare 34.66%
2 Consumer Staples 16.16%
3 Consumer Discretionary 9.31%
4 Communication Services 3.38%
5 Materials 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
376
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-26
Closed –
ISEE
377
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-32,300
Closed -$761K
RDUS
378
CALL
DELISTED
Radius Health, Inc.
RDUS
– –
-31,000
Closed -$2K
RDUS
379
DELISTED
Radius Health, Inc.
RDUS
– –
-28,116
Closed -$1.07M
RDUS
380
PUT
DELISTED
Radius Health, Inc.
RDUS
– –
-15,000
Closed -$188K
ALXN
381
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-16,335
Closed -$2M
DNKN
382
DELISTED
Dunkin' Brands Group, Inc.
DNKN
– –
-2,450
Closed -$131K
DNKN
383
PUT
DELISTED
Dunkin' Brands Group, Inc.
DNKN
– –
-10,000
Closed -$29K
MNK
384
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-11,500
Closed -$1K
MNK
385
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-22,200
Closed -$1.11M
MNK
386
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-22,200
Closed -$679K
CRAY
387
CALL
DELISTED
Cray, Inc.
CRAY
– –
-7,600
Closed -$2K
CRAY
388
PUT
DELISTED
Cray, Inc.
CRAY
– –
-5,100
Closed -$4K
GNCA
389
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-5,375
Closed -$37K
HZNP
390
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-41,900
Closed -$13K
TSRO
391
DELISTED
TESARO, Inc.
TSRO
– –
-1,880
Closed -$306K
AET
392
CALL
DELISTED
Aetna Inc
AET
– –
-23,600
Closed -$35K
AET
393
PUT
DELISTED
Aetna Inc
AET
– –
-5,000
Closed -$48K
COL
394
CALL
DELISTED
Rockwell Collins
COL
– –
-22,200
Closed -$84K
MON
395
DELISTED
Monsanto Co
MON
– –
-7,001
Closed -$775K
CBI
396
CALL
DELISTED
Chicago Bridge & Iron Nv
CBI
– –
-43,100
Closed -$94K
CASC
397
CALL
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
-10,800
Closed -$3K
CEMP
398
CALL
DELISTED
Cempra, Inc.
CEMP
– –
-102,000
Closed -$3K
CEMP
399
DELISTED
Cempra, Inc.
CEMP
– –
-200
Closed -$1K
CEMP
400
PUT
DELISTED
Cempra, Inc.
CEMP
– –
-200
Closed -$1K
13 14 15
16
17

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q1 2017 Portfolio in Review

As of Q1 2017, FT Options held 408 positions worth $76M, down 13% from $87.1M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options deployed $112M of net new capital in Q1 2017, opening 159 new positions and adding to 53 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 25,829 shares worth $3.12M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 45% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $9.7M trimmed.

  • FT Options's largest Q1 2017 buy was GW Pharmaceuticals Plc American Depositary Shares: 25,829 shares worth $3.12M.
  • FT Options added most to Kellanova in Q1 2017, an estimated $2.19M increase.
  • FT Options's biggest Q1 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $9.7M.
  • FT Options fully exited JPMorgan Chase in Q1 2017, selling an estimated $3.58M.
  • FT Options's ten largest holdings make up 38% of its $76M portfolio in Q1 2017.
  • FT Options opened 159 new positions and closed 131 in Q1 2017.
  • FT Options's portfolio value fell 13% quarter-over-quarter to $76M.

Based on FT Options's 13F filing for Q1 2017, filed 12 May 2017.